Veraxa is shifting away from animal testing to get drugs to market faster, calling it ‘not just a regulatory obligation, but a scientific opportunity.’ ...

An announcement from SGT German Private Equity GmbH & Co. KGaA ( ($DE:GTH) ) is now available. German Tech Holding GmbH & Co.

Completion of enrollment earlier this year and expected final PanCAN grant payment this quarter mark successful completion of a key phase of ...

AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in ...

A day after falling to a two-month low, Germany's equity benchmark DAX rebounded strongly on Friday as stocks gained in strength, buoyed by comments from U.S. President Donald Trump that the U.S. will ...

German Tech Holding is shifting focus toward AI and biotech, building on its venture capital roots and digital platform investments. The company is evaluating a 10% investment in Zirnostics, whose ...

VERAXA Biotech (VRXA) presented its first animal proof-of-concept results for BiTAC-ADC cancer therapy technology at the World ADC Congress. A single 3 mg/kg dose produced tumor regression in a breast ...

The Nasdaq 52-week range stood at USD 2.38 to USD 29.98 on October 15, 2026. Seres Therapeutics stock costs EUR 2.28 on ...

A massive wave of job cuts is looming in the German chemical industry. Three weeks ago, Evonik CEO Claus Rettig asserted he ...

Krystal Biotech, Inc. (NASDAQ:KRYS) has something most biotech companies spend years trying to achieve: a drug that works, is approved, and is already generating meaningful revenue. VYJUVEK, a gene ...

ASML shares rose as much as 3.6% in Amsterdam, lifting the European sector index by more than 1%. The stock has gained almost ...